Qiang Xu, Ph.D. Joins Frontage as the Vice President, Global Genomics Services
Dr. Qiang Xu has over 20 years of experience in drug discovery and development, clinical diagnostics, genomics, bioinformatics and AI/ML within CROs and sponsor companies in both US and China.
Prior to joining Frontage, Qiang was the Founder, President and CEO of GenomiCare, a precision medicine company with operations in both China and US for 10 years. Previously, he held various leadership roles in CRO companies including Senior Director of WuXi AppTec Genome Center, Director of R&D and Biomarker Services at AltheaDx, and multiple scientific and management roles in global pharmaceutical companies, including Novartis and Genentech.
Qiang is a subject matter expert in drug discovery and development, clinical diagnostics development with experience in CLIA/CAP/LDT and FDA 510(k)/PMA, genomics and multi-omics applications, RWD/RWE data integration, bioinformatics/software engineering and AI/ML applications in medicine and pharmaceuticals. Qiang’s experience and his understanding of P&L, interdisciplinary collaboration strategies, and leading cross-functional operation teams have led to successful completion of projects in a timely and cost-effective manner in his previous organizations.
Qiang received his Ph.D. degree in molecular biology and bioinformatics from UCLA/ University of California, Los Angeles, USA and a B.S. degree in biochemistry and molecular biology from Peking University, China. Qiang has over 50 scientific journal publications and over 40 patents in US and globally, to his credit.